NHI Q4 Normalized FFO $1.22/share, 2026 guidance $4.94-$4.99

NATIONAL HEALTH INVESTORS INC

2025-FY EPS reported $3.02 revenue$375,628,000

Q4 GAAP EPS $0.80 (vs $0.95 prior yr); NAREIT FFO $1.22; Normalized FFO $1.22 (vs $1.12).
FY 2025 Normalized FFO $4.91/share (vs $4.44), exceeding initial guidance midpoint by ~6%.
2026 guidance: NAREIT/Normalized FFO $4.94-$4.99, Normalized FAD $248.9M-$251.4M.
Total 2025 investments $392.3M; Feb 2026 acquired 9-property SHOP portfolio for $105.5M.
Net debt/Adj EBITDA 3.8x; $315.8M ATM availability; $110.6M LOI pipeline at ~7.5% yield.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.